Larimar Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Larimar Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2013 to Q3 2024.
  • Larimar Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 63.8M shares, a 45.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 63.8M +19.9M +45.3% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 63.8M +20.5M +47.5% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 63.8M +20.5M +47.4% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 43.9M +640K +1.48% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 43.9M +637K +1.47% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 43.3M +25.6M +144% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 43.3M +25.6M +144% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 43.3M +25.6M +144% Dec 31, 2022 10-K 2024-03-14
Q3 2022 43.3M +25.6M +144% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 17.7M +2.34M +15.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 17.7M +2.34M +15.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 17.7M +2.34M +15.2% Dec 31, 2021 10-K 2023-03-14
Q3 2021 17.7M +2.35M +15.3% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 15.4M +11.5K +0.08% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 15.4M -22.1M -59% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 15.4M +9.28M +152% Dec 31, 2020 10-K 2022-03-25
Q3 2020 15.4M -22M -58.9% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 15.4M -22M -58.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 37.5M +147K +0.39% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 6.09M -31.2M -83.7% Dec 31, 2019 10-K 2021-03-04
Q3 2019 37.4M +504K +1.37% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 37.3M +9.75M +35.3% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 37.3M +9.76M +35.4% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 37.3M +9.8M +35.6% Dec 31, 2018 10-K 2020-03-05
Q3 2018 36.9M +9.38M +34.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 27.6M +130K +0.47% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 27.6M +208K +0.76% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 27.5M +157K +0.57% Dec 31, 2017 10-K 2019-03-14
Q3 2017 27.5M +155K +0.57% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 27.4M +177K +0.65% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 27.4M +81.8K +0.3% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 27.3M +90K +0.33% Dec 31, 2016 10-K 2018-03-09
Q3 2016 27.3M +95.7K +0.35% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 27.3M +154K +0.57% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 27.3M +413K +1.54% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 27.2M +4.36M +19.1% Dec 31, 2015 10-K 2017-03-10
Q3 2015 27.2M +4.53M +19.9% Sep 30, 2015 10-Q 2015-11-13
Q2 2015 27.1M +4.41M +19.4% Jun 30, 2015 10-Q 2015-08-14
Q1 2015 26.9M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 22.9M +22.1M +3037% Dec 31, 2014 10-K 2016-03-15
Q3 2014 22.7M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 22.7M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 729K Dec 31, 2013 10-K 2015-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.